104 related articles for article (PubMed ID: 35468745)
1. Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10.
Yang J; Hou C; Wang H; Perez EA; Do-Umehara HC; Dong H; Arunagiri V; Tong F; Van Scoyk M; Cho M; Liu X; Ge X; Winn RA; Ridge KM; Wang X; Chandel NS; Liu J
Cancer Lett; 2023 Feb; 555():216025. PubMed ID: 36538983
[TBL] [Abstract][Full Text] [Related]
2. ASD/OCD-Linked Protocadherin-10 Regulates Synapse, But Not Axon, Development in the Amygdala and Contributes to Fear- and Anxiety-Related Behaviors.
Hoshina N; Johnson-Venkatesh EM; Rally VR; Sant J; Hoshina M; Seiglie MP; Umemori H
J Neurosci; 2022 May; 42(21):4250-4266. PubMed ID: 35504727
[TBL] [Abstract][Full Text] [Related]
3. delta-Protocadherins: a gene family expressed differentially in the mouse brain.
Vanhalst K; Kools P; Staes K; van Roy F; Redies C
Cell Mol Life Sci; 2005 Jun; 62(11):1247-59. PubMed ID: 15905963
[TBL] [Abstract][Full Text] [Related]
4. delta-Protocadherins: unique structures and functions.
Redies C; Vanhalst K; Roy Fv
Cell Mol Life Sci; 2005 Dec; 62(23):2840-52. PubMed ID: 16261259
[TBL] [Abstract][Full Text] [Related]
5. A C-terminal motif containing a PKC phosphorylation site regulates γ-Protocadherin-mediated dendrite arborization in the cerebral cortex
Hanes CM; Mah KM; Steffen DM; Marcucci CG; Fuller LC; Burgess RW; Garrett AM; Weiner JA
bioRxiv; 2024 Jan; ():. PubMed ID: 38328061
[TBL] [Abstract][Full Text] [Related]
6. How clustered protocadherin binding specificity is tuned for neuronal self-/nonself-recognition.
Goodman KM; Katsamba PS; Rubinstein R; Ahlsén G; Bahna F; Mannepalli S; Dan H; Sampogna RV; Shapiro L; Honig B
Elife; 2022 Mar; 11():. PubMed ID: 35253643
[TBL] [Abstract][Full Text] [Related]
7. Isoform requirement of clustered protocadherin for preventing neuronal apoptosis and neonatal lethality.
Kobayashi H; Takemoto K; Sanbo M; Hirabayashi M; Hirabayashi T; Hirayama T; Kiyonari H; Abe T; Yagi T
iScience; 2023 Jan; 26(1):105766. PubMed ID: 36582829
[TBL] [Abstract][Full Text] [Related]
8. The role of Pcdh10 in neurological disease and cancer.
Zhen Y; Pavez M; Li X
J Cancer Res Clin Oncol; 2023 Aug; 149(10):8153-8164. PubMed ID: 37058252
[TBL] [Abstract][Full Text] [Related]
9. Delta-protocadherins in health and disease.
Kahr I; Vandepoele K; van Roy F
Prog Mol Biol Transl Sci; 2013; 116():169-92. PubMed ID: 23481195
[TBL] [Abstract][Full Text] [Related]
10. Innovative mouse models for the tumor suppressor activity of Protocadherin-10 isoforms.
Kleinberger I; Sanders E; Staes K; Van Troys M; Hirano S; Hochepied T; Lemeire K; Martens L; Ampe C; van Roy F
BMC Cancer; 2022 Apr; 22(1):451. PubMed ID: 35468745
[TBL] [Abstract][Full Text] [Related]
11. PCDH10 is a candidate tumour suppressor gene in medulloblastoma.
Bertrand KC; Mack SC; Northcott PA; Garzia L; Dubuc A; Pfister SM; Rutka JT; Weiss WA; Taylor MD
Childs Nerv Syst; 2011 Aug; 27(8):1243-9. PubMed ID: 21597995
[TBL] [Abstract][Full Text] [Related]
12. Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis.
Jao TM; Tsai MH; Lio HY; Weng WT; Chen CC; Tzeng ST; Chang CY; Lai YC; Yen SJ; Yu SL; Yang YC
Int J Cancer; 2014 Dec; 135(11):2593-603. PubMed ID: 24740680
[TBL] [Abstract][Full Text] [Related]
13. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
